Omega 7 Oil and Inflammatory Biomarker Study

Completed · Not applicable · Has a placebo group

Conditions studied: Musculoskeletal Pain

In brief

The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of a single crossover is divided into 1:1 and each supplementation is three weeks with no washout in between.

Key facts

Study ID

NCT03669575

Run by

Bastyr University

People needed

56

Starts

2017-09-01

Expected to finish

2019-10-01

Last updated by the study team

2019-10-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Taking narcotic or opioid pain medication
• Unable to monitor NSAID or OTC pain medication quantity
• Unable to visit Kenmore Washington Clinical Research Center for three times
• Objection from his/her primary care doctor
• Employee or family member of Barlines Organics

Where it is running

• Bastyr University Clinical Research Center — Kenmore, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.